|1.||Niwa, Toshimitsu: 29 articles (05/2014 - 01/2002)|
|2.||Nishijima, Fuyuhiko: 17 articles (05/2014 - 01/2008)|
|3.||Shimizu, Hidehisa: 16 articles (05/2014 - 08/2009)|
|4.||Vanholder, Raymond: 7 articles (01/2015 - 02/2004)|
|5.||Saito, Hideyuki: 6 articles (09/2014 - 04/2007)|
|6.||Enomoto, Atsushi: 6 articles (05/2014 - 03/2003)|
|7.||Evenepoel, Pieter: 6 articles (01/2014 - 05/2009)|
|8.||Brunet, Philippe: 5 articles (04/2015 - 10/2003)|
|9.||Wu, Chih-Jen: 5 articles (01/2015 - 01/2011)|
|10.||Lin, Cheng-Jui: 5 articles (01/2015 - 01/2011)|
|1.||Chronic Kidney Failure (Chronic Renal Failure)
11/01/1997 - "In the present study, we determined whether an oral adsorbent (AST-120) could reduce the serum and urine levels of indoxyl sulfate and suppress the progression of chronic renal failure (CRF) in undialyzed uremic patients. "
01/01/2015 - "Medline, Cochrane, and EMBASE databases were searched until January 1, 2014 with combinations of the following keywords: chronic renal failure, end-stage kidney disease, uremic toxin, uremic retention, indoxyl sulfate, p-cresyl sulfate. "
01/01/2015 - "Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure."
01/01/2015 - "Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease."
06/17/2011 - "Uremic toxins such as indoxyl sulfate (IS) accumulate at a high level in end stage renal disease (ESRD) and can exhibit significant systemic endothelial toxicity leading to accelerated cardiovascular events. "
|2.||Renal Insufficiency (Renal Failure)
01/01/2001 - "An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats."
01/01/2012 - "In vitro and ex vivo data link both p-cresyl sulfate and indoxyl sulfate, two of the main compounds of this solute group, to negative impact on the cardiovascular system and progression of kidney failure. "
10/01/2003 - "Indoxyl sulfate administrated to uremic rats increases the rate of progression of renal failure. "
01/01/1999 - "Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure."
11/01/1997 - "The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients."
|3.||Blind Loop Syndrome (Bacterial Overgrowth Syndrome)
05/01/1973 - "This diagnostic procedure was applied to the identification of patients with steatorrhoea due to the stagnant loop syndrome, and was compared with other tests for this condition, viz, study of the small intestinal bacterial flora, urinary indican excretion, and the Schilling test with added intrinsic factor. "
01/01/1976 - "Value of urinary simple phenol and indican determinations in the diagnosis of the stagnant loop syndrome."
01/01/1976 - "When applied as diagnostic tests for the stagnant loop syndrome, the phenol excretion showed 2 false negative results, the p-cresol excretion 3 false negative and 2 false positive results, and the indican excretion 6 false positive results. "
01/01/1976 - "The mean excretion of the compounds in the patients with the stagnant loop syndrome and in the control patients, respectively, was 77 and 2.3 mg/24 h of phenol (p less than 0.05), 164 and 39.5 mg/24 h of p-cresol (n.s.), and 369 and 41.5 mg/24 h of indican (p less than 0.01). "
01/01/1976 - "The urinary excretion of phenol, p-cresol, and indican was determined in 7 patients with the stagnant loop syndrome, 26 patients with coeliac disease, chronic pancreatitis, and partial gastrectomy, and 18 control patients. "
|4.||Cardiovascular Diseases (Cardiovascular Disease)
01/01/2015 - "In CKD patients, the protein-bound uremic retention solute indoxyl sulfate (IS) is independently associated with cardiovascular disease. "
10/01/2014 - "Although this condition is often easily treated, diagnosing PUBS in chronic renal patients probably means an increased serum concentration of indoxyl sulfate, metabolite that is involved in the progression of both CKD and cardiovascular disease. "
03/15/2014 - "Emerging evidence suggests that uremic toxins, in particular indoxyl sulfate (IS) and p-cresyl sulfate (PCS), may be involved in the pathogenesis of cardiovascular disease. "
09/01/2013 - "p-Cresyl sulfate and indoxyl sulfate contribute to cardiovascular disease and progression of renal disease. "
01/01/2013 - "Indoxyl sulfate, a uremic toxin, is involved in endothelial dysfunction, and consequently, the pathogenesis of CKD-associated cardiovascular disease. "
03/01/1952 - "A study of the pulmonary tuberculous patients complicated with intestinal tuberculosis, particularly on the blood and the indican-quantity in the urine; III. A comparison of the indican-quantities on the urine between two groups, the pulmonary tuberculous patients complicated with and without intestinal tuberculosis."
10/01/1951 - "A study of the pulmonary tuberculous patients complicated with intestinal tuberculosis, particularly on the blood and the indican-quantity in the urine. "
03/01/1951 - "A study of the pulmonary tuberculous patients complicated with intestinal tuberculosis, particularly on the blood and the indican-quantity in the urine. "
08/01/1951 - "[Blood xanthoproteinic reaction and indican in tuberculosis in children]."
01/01/1981 - "The urine of healthy subjects was found to contain tryptophan, indican, tryptamine and urea, while that of tuberculosis patients--tryptophan metabolites, including 3-hydroxykynurenine, known as carcinogen. "
|2.||Staphylococcal Protein A (A, Protein)
|4.||Biological Markers (Surrogate Marker)
|5.||Phenol (Carbolic Acid)
|7.||Transforming Growth Factor beta1 (TGF beta 1)
|10.||Transforming Growth Factors (Transforming Growth Factor)
|1.||Protein-Restricted Diet (Diet, Protein Restricted)
|2.||Renal Dialysis (Hemodialysis)
|5.||Transplantation (Transplant Recipients)